Samuel Whiting - 04 Jan 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Medical Officer
Signature
/s/ Pierre Lorenzo, Attorney-in-Fact for Samuel Whiting
Issuer symbol
TPST
Transactions as of
04 Jan 2022
Net transactions value
$0
Form type
4
Filing time
06 Jan 2022, 18:25:12 UTC
Previous filing
30 Jun 2021
Next filing
10 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +29,000 $0.000000 29,000 04 Jan 2022 Common Stock 29,000 $5.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 4, 2022, subject to the reporting person's continued service.